Abstract
BackgroundTocilizumab (TCZ) is a monoclonal IL6-receptor antibody which is indicated in adult patients either as monotherapy or in combination with methotrexate for treatment of moderate to severe RA.1 Dosing is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
